Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.

Aging - 22 Jun 2021

Li Shaowen, Dong Chunli, Chen Jiayan, Gao Xiaocui, Xie Xiuying, Zhang Xin

Abstract excerpt

In this study, we performed a bioinformatics analysis to identify immune checkpoint genes (ICGs) associated with prognosis and the immunotherapeutic response in endometrial carcinoma (EC) patients. We classified 47 ICGs into high, medium, and low expression groups by performing RNA-sequencing data analysis of EC patient samples from The Cancer Genome Atlas (n = 521) and GSE77688 (n = 88) datasets. Univariate Cox...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptive Immunity
Share to Antigens, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Disease Resistance

Share to Endometrial Neoplasms

Share to Epithelial-Mesenchymal Transition

Share to Immunotherapy

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 34158412
DOI: 10.18632/aging.203189
PMCID: PMC8266314

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.PMID 34158412Read ↗

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and ChemotherapySemantic proximity Read ↗

Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironmentSemantic proximity Read ↗

Identification of clusters related to programmed cell death and potential prognostic biomarkers for immunotherapy response in endometrial cancerSemantic proximity Read ↗

Construction of the Novel Immune Risk Scoring System Related to CD8 + T Cells in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

Significance of Tumor Infiltrating Immune Cells (TIICs) in Endometrial carcinoma: A Bioinformatics AnalysisSemantic proximity Read ↗

Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.Semantic proximity Read ↗

Bioinformatic Profiling Identifies Prognosis-Related Genes in the Immune Microenvironment of Endometrial CarcinomaSemantic proximity Read ↗

Identification and Validation of TNFRSF4 as a High-profile Biomarker for Prognosis and Immunomodulation in Endometrial CarcinomaSemantic proximity Read ↗

Mining of clinical and prognosis related genes in the tumor microenvironment of endometrial cancerSemantic proximity Read ↗

Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinomaSemantic proximity Read ↗

Exploration of prognostic genes related to T cell-mediated tumor killing in uterine corpus endometrial cancer based on transcriptome data and experimental verificationSemantic proximity Read ↗

Identification of three subtypes of ovarian cancer and construction of prognostic models based on immune-related genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.